Detalles de la búsqueda
1.
Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.
Clin Infect Dis
; 46(6): 933-40, 2008 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18271750
2.
Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands.
Antivir Ther
; 15(6): 871-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20834099
3.
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.
AIDS
; 23(13): 1689-99, 2009 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-19487907
4.
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.
J Acquir Immune Defic Syndr
; 45(2): 183-92, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17414934
Resultados
1 -
4
de 4
1
Próxima >
>>